scholarly journals The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Decreases Bone Formation and Bone Mineral Density in Healthy Postmenopausal Women: A Randomized, Controlled Trial

2007 ◽  
Vol 92 (4) ◽  
pp. 1305-1310 ◽  
Author(s):  
Andrew Grey ◽  
Mark Bolland ◽  
Greg Gamble ◽  
Diana Wattie ◽  
Anne Horne ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Randomized Controlled Trial ◽  
Bone Formation ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Controlled Trial ◽  
Peroxisome Proliferator ◽  
Mineral Density ◽  
Peroxisome Proliferator Activated Receptor ◽  
Randomized Controlled

Unipedal standing exercise and hip bone mineral density in postmenopausal women: a randomized controlled trial

2009 ◽  
Vol 28 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Akinori Sakai ◽  
Toshihisa Oshige ◽  
Yukichi Zenke ◽  
Yoshiaki Yamanaka ◽  
Hitoshi Nagaishi ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Randomized Controlled Trial ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Controlled Trial ◽  
Mineral Density ◽  
Randomized Controlled ◽  
Unipedal Standing
Sign in / Sign up

Export Citation Format

Share Document